AL
UTHR icon

Airain Ltd’s United Therapeutics UTHR Stock Holding History

Airain Ltd’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$207K Sell
1,593
-11,588
-88% -$1.45M 0.01% 750
2017
Q1 		$1.78M Buy
+13,181
New +$2M 0.09% 245
2016
Q3 		– Sell
-59,959
Closed -$6.35M – 809
2016
Q2 		$6.35M Buy
59,959
+15,083
+34% +$1.68M 0.37% 78
2016
Q1 		$5M Buy
44,876
+42,474
+1,768% +$5.37M 0.35% 70
2015
Q4 		$376K Sell
2,402
-19,531
-89% -$2.84M 0.03% 535
2015
Q3 		$2.88M Sell
21,933
-42,819
-66% -$6.87M 0.17% 169
2015
Q2 		$11.3M Buy
64,752
+21,895
+51% +$3.94M 0.63% 22
2015
Q1 		$7.39M Sell
42,857
-20,035
-32% -$3.05M 0.45% 62
2014
Q4 		$8.14M Buy
62,892
+43,255
+220% +$5.57M 0.67% 30
2014
Q3 		$2.53M Sell
19,637
-21,931
-53% -$2.26M 0.17% 165
2014
Q2 		$3.68M Buy
+41,568
New +$4M 0.3% 86
2013
Q3 		– Sell
-27,131
Closed -$1.79M – 661
2013
Q2 		$1.79M Buy
+27,131
New +$1.75M 0.27% 83

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Airain Ltd's UTHR Position: Q2 2017 in Review

Airain Ltd reduced its United Therapeutics (UTHR) stake by 88% in Q2 2017, selling an estimated $1.45M and leaving 1,593 shares worth $207K. The position accounts for 0.01% of the portfolio, ranked #750.

Airain Ltd first reported a position in UTHR in Q2 2013 and has held it in 12 quarters since. The position peaked at $11.3M in Q2 2015. 373 funds tracked by Wall St. Rank hold UTHR as of Q2 2017.

  • Airain Ltd held 1,593 shares of United Therapeutics worth $207K as of Q2 2017.
  • Airain Ltd sold 11,588 United Therapeutics shares in Q2 2017, an estimated $1.45M.
  • United Therapeutics made up 0.01% of Airain Ltd's portfolio in Q2 2017, its #750 holding.
  • Airain Ltd first reported a position in United Therapeutics in Q2 2013 and has held it in 12 quarters since.
  • Airain Ltd's United Therapeutics position peaked at $11.3M in Q2 2015.
  • 373 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.